Ivy Capital
常春藤资本
Ivy Capital (常春藤资本) is a Chinese venture capital firm that shows up in elsewhere's corpus mainly through its deal activity: it led the Series A of Lymow, a robotic lawn-mower maker whose revenue passed 100 million yuan, in a round announced in September 2025 alongside Unity Ventures, Gobi and others ; earlier it participated as a co-investor in MKSemi's roughly 80-million-yuan low-power UWB chip round in 2023 and in a 2020 healthcare round backed by Morningside and Matrix Partners China . Beyond these transactions — which sketch a fund writing checks from healthcare to semiconductors to robotics, usually in syndicate — elsewhere's corpus does not carry a fuller profile of the firm itself.
AI-generated — may contain errors, please verify.
Coverage
Lymow Tech raises over 100 million yuan in three rounds within six months, robot mower revenue surpasses 100 million yuan, tens of thousands of units expected to be delivered this year | Unity Ventures portfolio newcomer
Continued Bullishness on China's Smart Hardware and Brand Globalization Tracks
Huanwei Microelectronics Completes Series A Round to Accelerate Low-Power UWB Chip Market Expansion and Mass Production
Accelerate adoption in smartphones, automotive, and industrial IoT applications.
瀚巍微电子完成Pre-A+轮融资，发布最新款超低功耗UWB芯片 Hanwei Microelectronics Completes Pre-A+ Round, Unveils New Ultra-Low-Power UWB Chip
Accelerate the adoption of new products in consumer electronics and industrial internet product segments.
Morningside-backed LifeTech Scientific raises over RMB 1.2 billion in new funding round | Light Moments
China's new drug R&D is undergoing a "Cambrian explosion." The industry's underlying infrastructure for pharmaceutical innovation is one of the core sectors we're tracking in healthcare.
